Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study

por Saad Alshahrani, Abdulaziz, Mohammad, Danah, attieh Alzahrani, Mohammad, Narula, Neeraj
Publicado 2023